These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31111467)

  • 1. Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta-analysis.
    Tundo A; de Filippis R; De Crescenzo F
    Acta Psychiatr Scand; 2019 Aug; 140(2):116-125. PubMed ID: 31111467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of 24-week pramipexole augmentation in patients with treatment resistant depression. A retrospective cohort study.
    Tundo A; Betro' S; Iommi M; de Filippis R
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jan; 112():110425. PubMed ID: 34375683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression.
    Goldberg JF; Burdick KE; Endick CJ
    Am J Psychiatry; 2004 Mar; 161(3):564-6. PubMed ID: 14992985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review.
    Sporn J; Ghaemi SN; Sambur MR; Rankin MA; Recht J; Sachs GS; Rosenbaum JF; Fava M
    Ann Clin Psychiatry; 2000 Sep; 12(3):137-40. PubMed ID: 10984002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pramipexole in treatment-resistant depression: a 16-week naturalistic study.
    Lattanzi L; Dell'Osso L; Cassano P; Pini S; Rucci P; Houck PR; Gemignani A; Battistini G; Bassi A; Abelli M; Cassano GB
    Bipolar Disord; 2002 Oct; 4(5):307-14. PubMed ID: 12479663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pramipexole Augmentation for Treatment-Resistant Unipolar and Bipolar Depression in the Real World: A Systematic Review and Meta-Analysis.
    Tundo A; Betro' S; de Filippis R; Marchetti F; Nacca D; Necci R; Iommi M
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study.
    Franco-Chaves JA; Mateus CF; Luckenbaugh DA; Martinez PE; Mallinger AG; Zarate CA
    J Affect Disord; 2013 Jul; 149(1-3):319-25. PubMed ID: 23517885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pramipexole: augmentation in the treatment of depressive symptoms.
    Gupta S; Vincent JL; Frank B
    CNS Spectr; 2006 Mar; 11(3):172-5. PubMed ID: 16575373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pramipexole, fluoxetine, and placebo in patients with major depression.
    Corrigan MH; Denahan AQ; Wright CE; Ragual RJ; Evans DL
    Depress Anxiety; 2000; 11(2):58-65. PubMed ID: 10812530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pramipexole in bipolar depression: a literature review and clinical recommendations].
    Dionys V; Sienaert P
    Tijdschr Psychiatr; 2021; 63(9):658-664. PubMed ID: 34647304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing efficacy/effectiveness and safety/tolerability profiles of adjunctive pramipexole in bipolar depression: acute versus long-term data.
    Dell'Osso B; Ketter TA
    Int Clin Psychopharmacol; 2013 Nov; 28(6):297-304. PubMed ID: 24081199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
    Goss AJ; Kaser M; Costafreda SG; Sahakian BJ; Fu CH
    J Clin Psychiatry; 2013 Nov; 74(11):1101-7. PubMed ID: 24330897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression.
    Dunner DL; D'Souza DN; Kajdasz DK; Detke MJ; Russell JM
    J Affect Disord; 2005 Jul; 87(1):115-9. PubMed ID: 15967235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy and Safety of Piribedil Relative to Pramipexole for the Treatment of Early Parkinson Disease: A Systematic Literature Review and Network Meta-Analysis.
    Chen X; Ren C; Li J; Wang S; Dron L; Harari O; Whittington C
    Clin Neuropharmacol; 2020; 43(4):100-106. PubMed ID: 32658035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
    Ghaemi SN; Ostacher MM; El-Mallakh RS; Borrelli D; Baldassano CF; Kelley ME; Filkowski MM; Hennen J; Sachs GS; Goodwin FK; Baldessarini RJ
    J Clin Psychiatry; 2010 Apr; 71(4):372-80. PubMed ID: 20409444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vortioxetine for depression in adults.
    Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron for the treatment of restless legs syndrome.
    Trotti LM; Becker LA
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007834. PubMed ID: 30609006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction.
    Burdick KE; Braga RJ; Nnadi CU; Shaya Y; Stearns WH; Malhotra AK
    J Clin Psychiatry; 2012 Jan; 73(1):103-12. PubMed ID: 22152405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.